Suppr超能文献

吡格列酮二元系统与亲水性载体的物理化学和药效学评价。

Physicochemical and pharmacodynamic evaluation of pioglitazone binary systems with hydrophilic carriers.

机构信息

a Department of Pharmaceutics, College of Pharmacy , King Saud University , Riyadh , KSA.

b Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy , Al-Azhar University , Assiut , Egypt.

出版信息

Pharm Dev Technol. 2019 Sep;24(7):883-890. doi: 10.1080/10837450.2019.1616300. Epub 2019 Jun 4.

Abstract

Pioglitazone (PGZ) is an antidiabetic agent belongs to thiazolidinediones. Binary systems of PGZ in the matrices of kollicoat IR (KL) and gelucire (GL) at different weight ratios were prepared by kneading and co-evaporation methods, respectively. The drug solid dispersions were characterized in terms of dissolution studies, differential scanning calorimetry (DSC), and X-ray powder diffraction (XRPD). The effects of PGZ-KL (1:4) solid dispersion on the body weight, blood glucose, renal and hepatic functions of the diabetic rats were evaluated. Enhanced drug dissolution was observed in the case of PGZ-KL binary systems depending on the drug to polymer weight ratio. A reduction of 39.7, 32.7 and 26.6% for diabetic control, PGZ untreated and PGZ-KL (1:4), respectively, was recorded after 2 weeks. PGZ-KL (1:4) solid dispersion also showed significantly lower glucose blood level ( < 0.05) compared to the diabetic control group along the period of experiment. The level of ALT was highly significantly decreased in the animal group treated with PGZ-KL solid dispersion ( < 0.001). However, treatment of diabetic rats with either PGZ-KL or PGZ untreated significantly reduced the level of creatinine compared to the diabetic control and the difference between them was non-significant.

摘要

吡格列酮(PGZ)是一种属于噻唑烷二酮类的抗糖尿病药物。通过揉捏和共蒸发方法分别将 PGZ 在 kollicoat IR(KL)和聚乙二醇 4000 二硬脂酸酯(GL)基质中的二元体系制备。根据溶解研究、差示扫描量热法(DSC)和 X 射线粉末衍射(XRPD)对药物固体分散体进行了表征。评估了 PGZ-KL(1:4)固体分散体对糖尿病大鼠体重、血糖、肾功能和肝功能的影响。

PGZ-KL 二元体系的药物溶解得到增强,这取决于药物与聚合物的重量比。在 2 周后,糖尿病对照组、未处理的 PGZ 组和 PGZ-KL(1:4)组的降低幅度分别为 39.7%、32.7%和 26.6%。PGZ-KL(1:4)固体分散体还显示出与糖尿病对照组相比,血糖水平显著降低(<0.05)。在用 PGZ-KL 固体分散体治疗的动物组中,ALT 水平显著降低(<0.001)。然而,与糖尿病对照组相比,用 PGZ-KL 或未处理的 PGZ 治疗糖尿病大鼠均显著降低了肌酐水平,且它们之间的差异无统计学意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验